MMP-7-IN-2 features a peptide-like inhibitory scaffold enabling analysis of metalloproteinase recognition and catalytic geometry. Functional groups shape binding affinity and solubility. Researchers evaluate its conformational dynamics during enzyme engagement. Uses include inhibitor profiling, mechanistic studies, and ligand optimization.
CAT No: R2491
CAS No:2848717-49-5
Synonyms/Alias:MMP-7-IN-2;CHEMBL5183142;2848717-49-5;EX-A8196;BDBM50589860;HY-153563;CS-0783940;
Mmp-7-IN-2 is a specialized small molecule inhibitor designed to selectively target matrix metalloproteinase-7 (MMP-7), an enzyme implicated in diverse physiological and pathological processes. Characterized by its high specificity and robust inhibitory activity, Mmp-7-IN-2 serves as a valuable tool compound for researchers seeking to dissect the biological functions of MMP-7 in vitro and in vivo. Its chemical structure enables efficient modulation of enzymatic activity, making it suitable for advanced mechanistic studies and pathway elucidation in molecular biology, biochemistry, and cell biology contexts. The reliable performance of Mmp-7-IN-2 supports its widespread adoption in academic and industrial laboratories focusing on extracellular matrix remodeling, tissue homeostasis, and related signaling cascades.
Enzyme Activity Studies: Mmp-7-IN-2 is frequently employed to investigate the catalytic role and substrate specificity of matrix metalloproteinase-7 in various biological systems. By selectively inhibiting MMP-7 activity, researchers can delineate the contributions of this protease to the degradation of extracellular matrix components, such as collagen and proteoglycans. This targeted approach enables the identification of downstream effects and compensatory mechanisms, facilitating a deeper understanding of tissue remodeling, repair, and pathological degradation processes.
Cancer Biology Research: In the context of oncology, Mmp-7-IN-2 has become an indispensable reagent for elucidating the involvement of MMP-7 in tumor progression, invasion, and metastasis. By blocking the proteolytic activity of MMP-7, scientists can assess its impact on tumor microenvironment modulation, cell migration, and angiogenesis. These studies provide valuable insights into the molecular mechanisms underlying cancer cell dissemination and offer a foundation for the development of novel therapeutic strategies targeting matrix metalloproteinases.
Fibrosis and Tissue Remodeling: The application of Mmp-7-IN-2 extends to the study of fibrotic diseases and tissue remodeling disorders, where aberrant MMP-7 activity contributes to pathological extracellular matrix turnover. Researchers utilize this inhibitor to model fibrogenesis in vitro and in animal models, enabling the evaluation of MMP-7's role in the progression of organ fibrosis. By modulating enzymatic activity, Mmp-7-IN-2 supports the identification of key regulatory pathways and potential molecular targets for anti-fibrotic interventions.
Inflammation and Immune Regulation: Mmp-7-IN-2 is also used to probe the participation of MMP-7 in inflammatory processes and immune cell function. Through the inhibition of MMP-7, investigators can assess changes in cytokine release, leukocyte infiltration, and the resolution of inflammation in various experimental models. This approach aids in clarifying the interplay between matrix remodeling enzymes and immune responses, advancing the understanding of chronic inflammatory diseases and tissue repair mechanisms.
Drug Discovery and Screening: The specificity and potency of Mmp-7-IN-2 make it a preferred tool in high-throughput screening assays aimed at identifying novel modulators of matrix metalloproteinases. Its use in assay development and validation allows for the accurate measurement of MMP-7 activity in complex biological samples, supporting the discovery of new small molecule inhibitors or biological therapeutics. By serving as a benchmark compound, Mmp-7-IN-2 accelerates the evaluation of lead candidates and the optimization of drug-like properties, ultimately contributing to the advancement of targeted intervention strategies in biomedical research.
In summary, Mmp-7-IN-2 is a versatile and scientifically valuable inhibitor that enables precise modulation of MMP-7 activity across a range of research disciplines. From fundamental studies on enzyme function and extracellular matrix dynamics to applied investigations in cancer biology, fibrosis, inflammation, and drug discovery, this compound provides researchers with the means to unravel complex biological processes and identify potential avenues for therapeutic innovation. Its integration into experimental workflows continues to drive progress in understanding the multifaceted roles of matrix metalloproteinases in health and disease.
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More